Records containing: Lymphoma, Non-Hodgkin
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study results posted · 2026-10-28Observational Cohort Study of People Living With HIV Treated With CD19-directed CAR T Cell Therapy for B-cell Lymphoid Malignancies
-
CLINICAL_TRIALS study record update · 2026-10-28Observational Cohort Study of People Living With HIV Treated With CD19-directed CAR T Cell Therapy for B-cell Lymphoid Malignancies
-
CLINICAL_TRIALS study results posted · 2026-08-12Electronic Health Mindfulness-based Music Therapy Intervention for Patients Undergoing Allogeneic Stem Cell Transplantation
-
CLINICAL_TRIALS study results posted · 2026-06-26A Phase 1/2 Study of the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of Relatlimab Plus Nivolumab in Pediatric and Young Adult Participants With Recurrent or Refractory Classical Hodgkin Lymphoma and Non-Hodgkin Lymphoma
-
CLINICAL_TRIALS study results posted · 2026-06-03A Phase II Pilot Study to Evaluate the Role of Siltuximab in Treatment of Cytokine Release Syndrome (CRS) and Immune Effector Cell Associated Neurotoxicity (ICANS) Related to Chimeric Antigen Receptor T-Cell Therapy (CAR-T) in Hematological Malignancies
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2026-04-24Lymphoid Malignancies and Precursors: Tissue Acquisition Protocol
-
CLINICAL_TRIALS study record update · 2026-04-22AI-based Predictive and Interventional System for Early Detection of Non-compliance Risks With Oral Therapies in Lymphoma Patients, Integrating the Complete Care Pathway and an Interoperable Clinical Interface With Algorithms Paired With Explainability Tools.
-
CLINICAL_TRIALS study record update · 2026-04-20A Phase 1 Study of NKX019, a CD19 Chimeric Antigen Receptor Natural Killer (CAR NK) Cell Therapy, in Subjects With B-cell Malignancies
-
CLINICAL_TRIALS study record update · 2026-04-20Expression of the Genome in Lymphoid Malignancies
-
CLINICAL_TRIALS study record update · 2026-04-17Long-Term Safety of Pirtobrutinib in Participants From Study J2N-MC-JZNJ With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Non-Hodgkin Lymphoma
-
CLINICAL_TRIALS study record update · 2026-04-14Biospecimen Procurement for Center for Immuno-Oncology Immunotherapy Protocols
-
CLINICAL_TRIALS study record update · 2026-04-13A Phase 1b/2, Multicenter, Open-label, Study of JNJ-90014496, an Autologous CD19/CD20 Bi-specific CAR-T Cell Therapy in Adult Participants With B-cell Non-Hodgkin Lymphoma
-
CLINICAL_TRIALS study record update · 2026-04-13A Phase 1, First-in-human Study of JNJ-80948543, a T-cell Redirecting Antibody, in Participants With NHL and CLL
-
CLINICAL_TRIALS study record update · 2026-04-13An Open Label, Rollover Platform Study for Continued Study Treatment and Ongoing Safety Monitoring
-
CLINICAL_TRIALS study record update · 2026-04-13eHealth Mindfulness-based Music Therapy Intervention for Patients Undergoing Stem Cell Transplantation
-
CLINICAL_TRIALS study record update · 2026-04-13Interrupting Sedentary Time to Improve Cardiometabolic Health and Toxicity in Patients With Lymphoma Receiving Chemotherapy: The iSTAND Trial
-
CLINICAL_TRIALS study record update · 2026-04-13A Phase 1b Study of JNJ-80948543 in Combination With Other CD3 T-Cell Engagers (TCEs) in Participants With Relapsed/Refractory B-Cell Non-Hodgkin Lymphoid (R/R B-Cell NHL) Malignancies
-
CLINICAL_TRIALS study record update · 2026-04-13A Phase 1, First-in-human Study of JNJ-87801493 in Combination With CD3 T-Cell Engagers in Participants With Relapsed/Refractory B-cell Non-Hodgkin Lymphoid Malignancies (NHLs)
-
CLINICAL_TRIALS study record update · 2026-04-13A Phase 1, First-in-Human Study of a Novel CD79bxCD20xCD3 Trispecific Antibody in B-Cell Non-Hodgkin Lymphoid Malignancies (NHLs)
-
CLINICAL_TRIALS study record update · 2026-04-13A Phase 1, First-in-Human, Dose Escalation Study of JNJ-88998377 in Participants With Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma (NHL)
-
CLINICAL_TRIALS study record update · 2026-04-09Long-term Follow-up Protocol for Subjects Treated With Adicet Allogeneic Gamma Delta (γδ) CAR T Cell Investigational Products
-
CLINICAL_TRIALS study record update · 2026-04-09A Phase 1b/2 Study to Evaluate the Safety and Efficacy of MK-1045 Monotherapy or in Combination With Other Anticancer Agents in Participants With Non-Hodgkin Lymphoma
-
CLINICAL_TRIALS study record update · 2026-04-02Targeted Agent and Profiling Utilization Registry (TAPUR) Study
-
CLINICAL_TRIALS study record update · 2026-04-02Phase I Trial of Tazemetostat in Combination With Venetoclax in Patients With Relapsed/Refractory Non-Hodgkin Lymphoma
-
CLINICAL_TRIALS study record update · 2026-03-27Canadian Profiling and Targeted Agent Utilization Trial (CAPTUR): A Phase II Basket Trial